Vermersch, Prof. Patrick
- Photo:
- Title: Prof.
- First name: Patrick
- Surname: Vermersch
- Position: M.D., Ph.D., Vice-president for research in biology and health at the University of Lille (France)
- Intro text (Career Carousel):
Together with his team, Jean was appointed to this position in January 2020. However, he joined Imcyse in March 2016 as Clinical Director and Independent Adviser. Jean has over 20 years’ experience in clinical trials management. He was for- merly Clinical Director at Sanofi Belgium and held various positions at Janssen Research Foundation, Inserm, Organon, Sanofi-Aventis and Novellas Healthcare. Jean holds a Ph.D. in Biomedical Sciences from the Faculty of Medicine, University of Brussels (ULB). A man of many talents, Jean enjoys spending time with his wife by selecting a perfectly aged wine from their wine list and pairing it with...
- Quote (Career Carousel):
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Patrick Vermersch studied medicine at the University Hospital in Lille, France, where he graduated in neurology. He then completed his education in more basic research fields, mainly in cellular biology between 1990 and 1994 with a PhD focused on biochemical abnormalities associated with Alzheimer’s and other neurodegenerative diseases. He has also conducted research related to the characterisations of post-transcriptional anomalies of Tau proteins. His research interests then turned to multiple sclerosis (MS). In the year 2000, he created with colleagues the first MS network in northern France to improve both care and research into MS.
Prof. Vermersch is in a department of neurology at the University of Lille, which deals with MS and other neuroinflammatory diseases. The department’s principal scientific interests are neuroimmunology and markers of disease evolution. In 2019 he became a board member of the European Charcot Foundation.
Prof. Vermersch is currently vice-president for research in biology and health at the University of Lille. His current areas of interest are prognostic markers of MS, development of new therapeutic targets and neuroimmunology in general. He participates in many therapeutic protocols on MS as member of steering committees. He has published approximately 420 scientific papers as author or co-author.
- Hits: 4096
